HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cold antibody autoimmune hemolytic anemia and lymphoproliferative disorders: a retrospective study of 20 patients including clinical, hematological, and molecular findings.

Abstract
A total of 20 patients with cold antibody hemolytic anemia were evaluated in a retrospective study of them, 15 had a monoclonal gammopathy of unknown significance (MGUS): 14 with MGUS of immunoglobulin M (IgM) subtype and 1 with immunoglobulin G subtype. One patient had smoldering Waldenström's macroglobulinemia, but four patients had no monoclonal protein and no evidence of lymphoma. However, in three of these patients, we were able to demonstrate a (mono-)clonal rearrangement of their immunoglobulin heavy and/or light chains. Of the 20 patients, 5 had IgHV34 nucleotide sequence indicating that the antibody was directed against the "I" antigen. Two patients exhibited a progressive increase of IgM over time, however without increasing hemolytic activity. Moreover, in two patients with long-term follow-up, we were able to correlate recurrent hemolytic activity with low environmental temperatures. Among four patients treated with rituximab, all four responded to treatment. However, treatment effect was only transient in all of them.
AuthorsCathrin Arthold, Cathrin Skrabs, Gerlinde Mitterbauer-Hohendanner, Renate Thalhammer, Ingrid Simonitsch-Klupp, Simon Panzer, Peter Valent, Klaus Lechner, Ulrich Jäger, Christian Sillaber
JournalWiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 126 Issue 11-12 Pg. 376-82 (Jun 2014) ISSN: 1613-7671 [Electronic] Austria
PMID24842748 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Autoantibodies
  • Immunologic Factors
  • Rituximab
Topics
  • Aged
  • Anemia, Hemolytic, Autoimmune (diagnosis, drug therapy, immunology)
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Autoantibodies (immunology)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Lymphoproliferative Disorders (diagnosis, drug therapy, immunology)
  • Male
  • Retrospective Studies
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: